The Asia Pacific Markets for Pcr Technologies

During the past three decades since its invention, PCR has evolved to become one of the fundamental technology platforms in life sciences sector. The application segments of this platform are still expanding, driven by the expiry of key PCR patents. The demand for fast, accurate, and affordable diagnosis tests in healthcare segment has been another key driver of the PCR market. The rising investments in the field of companion diagnostics have also been boosting the demand for PCR. Food safety testing is another significant end-use segment of the technology, driven by both consumer demand and regulatory requirements.

While developed countries still dominate the PCR market, the emerging markets are showing strong growth trends. In this latest study titled “The Asia Pacific Markets for PCR Technologies”, AcuBiz Consulting analysts identify market dynamics in various countries in the Asia Pacific (APAC) region and forecasts the potential of the market related to product segments, technology segments, and end-use segments. The global demand was around $10.6 billion in 2013. Even though North America had highest market share in 2013, the Asia Pacific region is forecasted to grow at a CAGR of over 11% during the same period between 2013 and 2018.

The report estimates the market size of the key product and application segments of PCR and forecasts the growth based on market dynamics of these segments, which can impact the demand for PCR. Various technology segments are also analysed in detail.

The study assesses alternate platforms that can potentially impact the demand for PCR. Evolving trends with respect to various aspects of PCR technology are also analysed in detail. Regulatory landscape of the key regional markets and end-use segments are also included in the report, since regulatory requirements directly impact the demand for PCR based tests.

Finally, the report analyses the activities of key players in the market. The company profile section includes 55...